Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2020

01-12-2020 | Metastasis | ASO Author Reflections

ASO Author Reflections: Is Sentinel Lymph Node Biopsy Necessary in Patients with Ductal Carcinoma In Situ with Microinvasion Diagnosed on Core Biopsy?

Authors: April Phantana-angkool, MD, Richard L. White Jr., MD, FACS

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

Whether or not to perform sentinel lymph node biopsy (SLNB) when microinvasive cancer or ductal carcinoma in situ with microinvasion (DCISM) is found on core biopsy is unknown. In contrast to pure ductal carcinoma in situ (DCIS), where multiple studies have identified predictors of upstaging, little is known about DCISM. Low rates of lymph node metastasis have been reported in DCISM.1,2 The upstaging rates for DCISM to measurable invasive cancer are variable.3,4 …
Literature
1.
Matsen CB, Hirsch A, Eaton A, et al. Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Ann Surg Oncol. 2014;21:3330–3335.CrossRef
2.
Ko BS, Lim WS, Kim HJ, et al. Risk factor for axillary lymph node metastases in microinvasive breast cancer. Ann Surg Oncol. 2012;19:212–216.CrossRef
3.
Namm JP, Mueller J, Kocherginsky M, Kulkarni S. The utility of sentinel lymph node biopsy in patients with ductal carcinoma in situ suspicious for microinvasion on core biopsy. Ann Surg Oncol. 2015;22:59–65.CrossRef
4.
5.
Phantana-angkool A, Voci AL, Warren YE, et al. Ductal carcinoma in situ with microinvasion on core biopsy: evaluating tumor upstaging rate, lymph node metastasis rate, and associated predictive variables. Ann Surg Oncol. 2019; 26:3874–3882.CrossRef
Metadata
Title
ASO Author Reflections: Is Sentinel Lymph Node Biopsy Necessary in Patients with Ductal Carcinoma In Situ with Microinvasion Diagnosed on Core Biopsy?
Authors
April Phantana-angkool, MD
Richard L. White Jr., MD, FACS
Publication date
01-12-2020
Publisher
Springer International Publishing
Keyword
Metastasis
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-08006-2

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Targeting the Immunosuppressive Tumor Microenvironment for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer

Announcement

Society of Surgical Oncology SSO 2020 – International Conference on Surgical Cancer Care

ASO Author Reflections

ASO Author Reflections: What is the Optimal Method of Digestive Reconstruction Following Pharyngolaryngectomy with Total Esophagectomy?

ASO Author Reflections

ASO Author Reflections: The Oncologic Efficacy and Feasibility of Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma

ASO Author Reflections

ASO Author Reflections: Robotic ALPPS: The Future is Coming

ASO Author Reflections

ASO Author Reflections: Lobular Carcinoma of the Breast: Why Does the Incidence Continue to Rise?